| Up
2006P-0450:
Revoke Approval of Allergan's Supplemental NDA #21-257/S-013 for
Lumigan (Bimatoprost Ophthalmic Solution 0.03%) and Deny Alcon's
Supplemental NDA for Travatan (Travoprost Ophthalmic Solution 0.004%)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| ACK1
|
| 11/02/2006
|
| 11/02/2006
|
| Federal Government
|
| FDA/DDM to Pfizer
Inc
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| Jennie C. Butler
|
|
|
|
|
| CP1
|
| 11/02/2006
|
| 11/02/2006
|
| Private Industry
|
| Pfizer Inc
|
|
|
|
|
|
|
| Table
of Contents
|
|
|
|
|
| Signature:
|
| Alessandra Ravetti
|
|
|
|
|
| C1
|
| 11/06/2006
|
| 11/06/2006
|
| Individual Consumer
|
| D. Lowe
|
|
|
|
|
|
|
|
|
|
|
|
Top | Up
Page last updated
November 8, 2006
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |
